Chandra Bhagat Pharma Limited (BOM:542934)

India · Delayed Price · Currency is INR

36.00

-0.63 (-1.72%)

At close: Jul 14, 2026

-37.88% (1Y)

Market Cap	271.62M -62.1%
Revenue (ttm)	1.16B +31.0%
Net Income	30.46M +255.1%
EPS	4.04 +255.3%
Shares Out	7.55M
PE Ratio	8.91
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,000
Open	37.00
Previous Close	36.63
Day's Range	35.00 - 37.00
52-Week Range	29.70 - 59.00
Beta	-0.16
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Chandra Bhagat Pharma

Chandra Bhagat Pharma Limited engages in the marketing of pharmaceutical critical care and health care products in India and internationally. It offers pharmaceutical formulations, including intravenous and intramuscular injections, tablets, and capsules in various therapeutic categories, such as anti-cancer, antibiotics, anesthesia, hormones, orthopedic, cardiac, cardiovascular, anti-fungal, antiviral, pediatrics, cardiology, nephrology, and neurology to Hospitals and Health care Centers through distribution networks and sales force under its ... [Read more]

Industry Drugs, Drug Proprietaries, and Druggists' Sundries

Founded 1944

Employees 40

Stock Exchange Bombay Stock Exchange

Ticker Symbol 542934

Full Company Profile

Financial Performance

In fiscal year 2026, Chandra Bhagat Pharma's revenue was 1.16 billion, an increase of 30.99% compared to the previous year's 887.67 million. Earnings were 30.46 million, an increase of 255.11%.

Financial Statements